Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

CHRSCHRS
Showing 7 of 26 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in COHERUS ONCOLOGY INC

Yes. Two Sigma holds 2,259,412 shares of CHRS (Coherus Oncology), worth $3.2M, as of its Q2 2026 13F filing. It reduced the position by 42,589 shares (-1.9%) from Q1 2026. Two Sigma has held CHRS since Q3 2025, across 4 quarterly 13F filings.

Current Value

$3.2M

Current Shares

2.3M

Total Value Change

+$2.5M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.3M
-1.9%
$3.2M0.0%$1.40
0
2026-Q1
Increased
2.3M
+356.9%
$3.9M0.0%$1.69
43
2025-Q4
Increased
503,875
+1310.9%
$715,5020.0%$1.42
40
2025-Q3
New
35,712
-
$58,5680.0%$1.64
29
2025-Q1
Exited
0
-100.0%
$00.0%$0.81
0
2024-Q4
Decreased
134,138
-80.3%
$185,1100.0%$1.38
0
2024-Q3
Decreased
682,380
-18.2%
$709,6750.0%$1.04
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used